2002
DOI: 10.1016/s0165-5728(02)00165-0
|View full text |Cite
|
Sign up to set email alerts
|

The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
96
1
6

Year Published

2005
2005
2024
2024

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 119 publications
(107 citation statements)
references
References 36 publications
3
96
1
6
Order By: Relevance
“…The decrease of IL-2 production in Group 3 treated with 1 mg/kg tramadol was due to insufficient pain relief or immunosuppression mediated via μ-receptor. This was confirmed by several experiments (Sacerdote et al, 1997;1999;Gaspani et al, 2002). It showed that IL-2 and morphine exerted similar effects in various aspects by decreasing intracellular adenosine 3',5'-cyclic phosphate (cAMP) content, modulating neuroendocrine activity, suppressing afferent sensory transmission and serving as Ca 2+ channel blockers (Plata-Salamán and Ffrench-Mullen, 1993;Song et al, 2002a).…”
Section: Modulation Of Cytokine Production By Tramadolmentioning
confidence: 66%
See 2 more Smart Citations
“…The decrease of IL-2 production in Group 3 treated with 1 mg/kg tramadol was due to insufficient pain relief or immunosuppression mediated via μ-receptor. This was confirmed by several experiments (Sacerdote et al, 1997;1999;Gaspani et al, 2002). It showed that IL-2 and morphine exerted similar effects in various aspects by decreasing intracellular adenosine 3',5'-cyclic phosphate (cAMP) content, modulating neuroendocrine activity, suppressing afferent sensory transmission and serving as Ca 2+ channel blockers (Plata-Salamán and Ffrench-Mullen, 1993;Song et al, 2002a).…”
Section: Modulation Of Cytokine Production By Tramadolmentioning
confidence: 66%
“…First, the decrease of IL-2 production treated with low dose of tramadol may be due to its affinity to μ-receptor, while with higher dose the non-opioid mechanism may play a key role in immunomodulation by tramadol. Second, the effects of tramadol on cytokine production may be mainly attributed to the intrinsic immunomodulatory properties of tramadol taken perioperatively, due to the serotonergic descending inhibitory system, including the increase of the serotonergic tone that has been usually associated with stimulation of lymphocyte proliferation, increase of IL-2 production and decrease of IL-6 production, can help to attenuate postoperative immunosuppression (Sacerdote et al, 1997;1999;Gaspani et al, 2002;Wang et al, 2003). In short, the antinociceptive mechanism of tramadol combined with the opioid and serotonergic system may play an important role in immune responses.…”
Section: Modulation Of Cytokine Production By Tramadolmentioning
confidence: 99%
See 1 more Smart Citation
“…Based on observations that applied in analgesic doses, tramadol and morphine exert different immune responses in both humans and rodents. Concomitant with a reciprocal effect on natural killer cell activity, 19,22,23 it is conceivable that the outcome regarding the engulfing function of the phagocytic cells will proceed through different pathways. Moreover, and in contrast to other opioids, the analgesic action of tramadol is only partially inhibited by the opioid antagonist naloxone, which suggests the existence of another mechanism of action.…”
Section: Discussionmentioning
confidence: 99%
“…Opioids could potentially be associated with a longer survival due to improvements in pain, as higher pain scores in patients with cancer are associated with a shorter survival [17][18][19][20]. The chronic effects of opioids on survival could include effects on cancer growth which might be mediated by direct effects of opioids on host cells (including angiogenesis or actions on immune cells) or cancer cells (including cancer cell development, apoptosis and metastasis) [21][22][23][24][25], Figure 1. Opioids can inhibit components of both innate and adaptive immunity [21,22,26,27], although a recent systematic review of non-surgical patients with cancer did not find any studies which correlated immune function to clinical outcomes (e.g.…”
Section: Introductionmentioning
confidence: 99%